Lin Chang
#141,499
Most Influential Person Now
Researcher
Lin Chang's AcademicInfluence.com Rankings
Lin Changengineering Degrees
Engineering
#5320
World Rank
#6570
Historical Rank
Electrical Engineering
#1471
World Rank
#1565
Historical Rank
Lin Changcomputer-science Degrees
Computer Science
#6812
World Rank
#7177
Historical Rank
Computational Linguistics
#1256
World Rank
#1270
Historical Rank
Machine Learning
#2332
World Rank
#2361
Historical Rank
Artificial Intelligence
#2607
World Rank
#2648
Historical Rank
Download Badge
Engineering Computer Science
Lin Chang's Degrees
- PhD Computer Science Stanford University
- Masters Electrical Engineering University of California, Berkeley
- Bachelors Computer Engineering University of California, Berkeley
Similar Degrees You Can Earn
Why Is Lin Chang Influential?
(Suggest an Edit or Addition)Lin Chang's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- FUNCTIONAL BOWEL DISORDERS (2018) (2425)
- Bowel Disorders. (2016) (1097)
- Gender, age, society, culture, and the patient's perspective in the functional gastrointestinal disorders. (2006) (356)
- Gender differences in irritable bowel syndrome. (2002) (344)
- Sex-related differences in IBS patients: central processing of visceral stimuli. (2003) (286)
- Differences in brain responses to visceral pain between patients with irritable bowel syndrome and ulcerative colitis (2005) (276)
- Association between early adverse life events and irritable bowel syndrome. (2012) (250)
- Gender-related differences in IBS symptoms (2001) (227)
- Development and Validation of the Rome IV Diagnostic Questionnaire for Adults (2016) (219)
- Rome IV Diagnostic Questionnaires and Tables for Investigators and Clinicians. (2016) (217)
- Irritable Bowel Syndrome Patients Show Enhanced Modulation of Visceral Perception by Auditory Stress (2003) (210)
- Differences in somatic perception in female patients with irritable bowel syndrome with and without fibromyalgia (2000) (209)
- The Central Role of Gastrointestinal-Specific Anxiety in Irritable Bowel Syndrome: Further Validation of the Visceral Sensitivity Index (2007) (207)
- The role of stress on physiologic responses and clinical symptoms in irritable bowel syndrome. (2011) (199)
- Longitudinal change in perceptual and brain activation response to visceral stimuli in irritable bowel syndrome patients. (2006) (196)
- Clinical determinants of health-related quality of life in patients with irritable bowel syndrome. (2004) (195)
- Is Irritable Bowel Syndrome a Diagnosis of Exclusion?: A Survey of Primary Care Providers, Gastroenterologists, and IBS Experts (2010) (190)
- Sensation of bloating and visible abdominal distension in patients with irritable bowel syndrome (2001) (189)
- Development of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) Gastrointestinal Symptom Scales (2014) (176)
- A Randomized Placebo-Controlled Phase IIb Trial of A3309, A Bile Acid Transporter Inhibitor, for Chronic Idiopathic Constipation (2011) (162)
- Prevalence of irritable bowel syndrome among university students: the roles of worry, neuroticism, anxiety sensitivity and visceral anxiety. (2003) (160)
- Childhood trauma is associated with hypothalamic-pituitary-adrenal axis responsiveness in irritable bowel syndrome. (2009) (160)
- Incidence of Ischemic Colitis and Serious Complications of Constipation Among Patients Using Alosetron: Systematic Review of Clinical Trials and Post-Marketing Surveillance Data (2006) (157)
- Condition-specific deactivation of brain regions by 5-HT3 receptor antagonist Alosetron. (2002) (143)
- Serum and Colonic Mucosal Immune Markers in Irritable Bowel Syndrome (2012) (138)
- Characterization of the Alternating Bowel Habit Subtype in Patients with Irritable Bowel Syndrome (2005) (135)
- A Dose-Ranging, Phase II Study of the Efficacy and Safety of Alosetron in Men with Diarrhea-Predominant IBS (2005) (132)
- Symptom differences in moderate to severe IBS patients based on predominant bowel habit (1999) (131)
- Brain Responses to Visceral and Somatic Stimuli in Patients With Irritable Bowel Syndrome With and Without Fibromyalgia (2003) (127)
- Chronic Constipation (1928) (126)
- Diagnosis and management of IBS (2010) (124)
- Do fluctuations in ovarian hormones affect gastrointestinal symptoms in women with irritable bowel syndrome? (2009) (120)
- American Gastroenterological Association Institute Technical Review on the pharmacological management of irritable bowel syndrome. (2014) (118)
- Predictors of Patient-Assessed Illness Severity in Irritable Bowel Syndrome (2008) (114)
- Stress and the gastrointestinal tract. V. Stress and irritable bowel syndrome (2001) (112)
- A Focus Group Assessment of Patient Perspectives on Irritable Bowel Syndrome and Illness Severity (2009) (111)
- Gallstone Pancreatitis: A Prospective Study on the Incidence of Cholangitis and Clinical Predictors of Retained Common Bile Duct Stones (1998) (111)
- Functional variants in the sucrase–isomaltase gene associate with increased risk of irritable bowel syndrome (2016) (107)
- Effect of sex on perception of rectosigmoid stimuli in irritable bowel syndrome. (2006) (102)
- Sex‐based differences in gastrointestinal pain (2004) (97)
- Impact of Sex and Gender on Irritable Bowel Syndrome (2003) (94)
- Bacterial Overgrowth and Irritable Bowel Syndrome: Unifying Hypothesis or a Spurious Consequence of Proton Pump Inhibitors? (2008) (87)
- Basic Pathophysiologic Mechanisms in Irritable Bowel Syndrome (2001) (84)
- Utility of the Rome I and Rome II criteria for irritable bowel syndrome in U.S. women (2002) (78)
- Gastrointestinal and Psychological Mediators of Health-Related Quality of Life in IBS and IBD: A Structural Equation Modeling Analysis (2012) (76)
- Is a negative colonoscopy associated with reassurance or improved health-related quality of life in irritable bowel syndrome? (2005) (74)
- Brain responses to visceral and somatic stimuli in irritable bowel syndrome: a central nervous system disorder? (2005) (71)
- Challenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles. (2008) (71)
- Irritable bowel syndrome: current approach to symptoms, evaluation, and treatment. (2007) (70)
- Developing Valid and Reliable Health Utilities in Irritable Bowel Syndrome: Results From the IBS PROOF Cohort (2009) (65)
- Impact of irritable bowel syndrome on patients' lives: development and psychometric documentation of a disease-specific measure for use in clinical trials (2005) (64)
- Correlation of symptom criteria with perception thresholds during rectosigmoid distension in irritable bowel syndrome patients (2000) (64)
- Systemic sclerosis is associated with specific alterations in gastrointestinal microbiota in two independent cohorts (2017) (63)
- Ischemic Colitis and Complications of Constipation Associated With the Use of Alosetron Under a Risk Management Plan: Clinical Characteristics, Outcomes, and Incidences (2010) (61)
- Increased Prevalence of Rare Sucrase-isomaltase (SI) Pathogenic Variants in Irritable Bowel Syndrome Patients (2018) (55)
- New insights into the pathophysiology of irritable bowel syndrome: Implications for future treatments (2005) (51)
- GERD Symptoms in the General Population: Prevalence and Severity Versus Care-Seeking Patients (2014) (51)
- A 9-year evaluation of temporal trends in alosetron postmarketing safety under the risk management program (2013) (49)
- Enhanced preattentive central nervous system reactivity in irritable bowel syndrome (2002) (49)
- Comparison of Symptoms, Healthcare Utilization, and Treatment in Diagnosed and Undiagnosed Individuals With Diarrhea-Predominant Irritable Bowel Syndrome (2017) (47)
- Female-Specific Association Between Variants on Chromosome 9 and Self-Reported Diagnosis of Irritable Bowel Syndrome. (2018) (45)
- Expression of the Bitter Taste Receptor, T2R38, in Enteroendocrine Cells of the Colonic Mucosa of Overweight/Obese vs. Lean Subjects (2016) (45)
- Current and emergent pharmacologic treatments for irritable bowel syndrome with diarrhea: evidence-based treatment in practice (2017) (43)
- Racial Differences in the Impact of Irritable Bowel Syndrome on Health-Related Quality of Life (2004) (43)
- Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders (2021) (41)
- Functional Bowel Disorders: A Roadmap to Guide the Next Generation of Research. (2017) (41)
- Understanding Gastrointestinal Distress: A Framework for Clinical Practice (2011) (41)
- A double blind parallel group pilot study of the effects of CJ-11,974 and placebo on perceptual and emotional responses to rectosigmoid distension in IBS patients (2000) (40)
- Differences in Gastrointestinal Symptoms According to Gender in Rome II Positive IBS and Dyspepsia in a Latin American Population (2010) (40)
- Irritable bowel syndrome patients have SCN5A channelopathies that lead to decreased NaV1.5 current and mechanosensitivity. (2018) (38)
- The effect of sex and irritable bowel syndrome on HPA axis response and peripheral glucocorticoid receptor expression (2016) (36)
- Computer-Generated Vs. Physician-Documented History of Present Illness (HPI): Results of a Blinded Comparison (2015) (35)
- Diagnosis and treatment of irritable bowel syndrome: State of the art (2005) (33)
- Responsiveness to Change and Minimally Important Differences of the Patient-Reported Outcomes Measurement Information System Gastrointestinal Symptoms Scales (2017) (30)
- Utility of the Rome I and Rome II criteria for irritable bowel syndrome in U.S. women. (2002) (29)
- Development of an Online Library of Patient-Reported Outcome Measures in Gastroenterology: The GI-PRO Database (2014) (29)
- Interactions of early adversity with stress-related gene polymorphisms impact regional brain structure in females (2016) (28)
- Identification of a Functional TPH1 Polymorphism Associated With Irritable Bowel Syndrome Bowel Habit Subtypes (2013) (27)
- A Review of the Evidence and Recommendations on Communication Skills and the Patient-Provider Relationship (PPR): A Rome Foundation Working Team Report. (2021) (27)
- Predictors of Health-related Quality of Life in Irritable Bowel Syndrome Patients Compared With Healthy Individuals (2018) (26)
- Autonomic and neuroendocrine responses to rectosigmoid stimulation (1998) (26)
- Is there a difference between abdominal pain and discomfort in moderate to severe IBS patients? (2002) (25)
- Characteristics of Acute Pain Attacks in Patients With Irritable Bowel Syndrome Meeting Rome III Criteria (2011) (25)
- Original ContributionsCorrelation of symptom criteria with perception thresholds during rectosigmoid distension in irritable bowel syndrome patients (2000) (25)
- Rome Foundation Endpoints and Outcomes Conference 2009: Optimizing Clinical Trials in FGID (2010) (25)
- Neuroendocrine and neuroimmune markers in IBS: pathophysiological role or epiphenomenon? (2006) (24)
- New Treatments for Irritable Bowel Syndrome in Women (2008) (23)
- Construct Validity of the Patient‐Reported Outcomes Measurement Information System Gastrointestinal Symptom Scales in Systemic Sclerosis (2014) (23)
- Risk and Protective Factors Related to Early Adverse Life Events in Irritable Bowel Syndrome (2020) (20)
- AGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert Review. (2022) (19)
- Emerging pharmacological therapies for the irritable bowel syndrome. (2011) (19)
- µ‐opioid receptor, β‐endorphin, and cannabinoid receptor‐2 are increased in the colonic mucosa of irritable bowel syndrome patients (2019) (18)
- Repeat treatment with rifaximin improves irritable bowel syndrome-related quality of life: a secondary analysis of a randomized, double-blind, placebo-controlled trial (2017) (18)
- Negative Events During Adulthood are Associated With Symptom Severity and Altered Stress Response in Patients With Irritable Bowel Syndrome. (2019) (18)
- Sigmoid colon mucosal gene expression supports alterations of neuronal signaling in irritable bowel syndrome with constipation. (2018) (18)
- Computer versus physician identification of gastrointestinal alarm features (2015) (17)
- Enhanced preattentive central nervous system reactivity in irritable bowel syndrome. (2002) (16)
- Novel techniques to study visceral hypersensitivity in irritable bowel syndrome (2008) (16)
- Irritable bowel syndrome: new and emerging therapies (2006) (15)
- The role of resilience in irritable bowel syndrome, other chronic gastrointestinal conditions and the general population. (2020) (15)
- Updates to the Rome Criteria for Irritable Bowel Syndrome. (2017) (13)
- Sex-Related Differences in GI Disorders. (2017) (13)
- Analysis of brain networks and fecal metabolites reveals brain–gut alterations in premenopausal females with irritable bowel syndrome (2020) (13)
- Epigenetic Mechanisms in Irritable Bowel Syndrome (2020) (13)
- The Colonic Mucosal MicroRNAs, MicroRNA-219a-5p and MicroRNA-338-3p, are Downregulated in Irritable Bowel Syndrome and are Associated with Barrier Function and MAPK signaling. (2021) (13)
- Irritable Bowel Syndrome: A Survey of Nurses’ Knowledge (2001) (13)
- The coexistence of fibromyalgia (FM) alters rectal perception before and after sigmoid stimulation in female IBS patients (1998) (12)
- Plasma Corticotropin-Releasing Factor Receptors and B7-2+ Extracellular Vesicles in Blood Correlate with Irritable Bowel Syndrome Disease Severity (2019) (12)
- Impact of patient and disease characteristics on the efficacy and safety of eluxadoline for IBS-D: a subgroup analysis of phase III trials (2019) (12)
- Postmenopausal women with irritable bowel syndrome (IBS) have more severe symptoms than premenopausal women with IBS (2020) (12)
- A review of three educational projects using interactive theater to improve physician-patient communication when treating patients with irritable bowel syndrome. (2015) (11)
- Does mind-body medicine have a role in gastroenterology? (1997) (11)
- AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Diarrhea. (2022) (10)
- Latest Insights on the Pathogenesis of Irritable Bowel Syndrome. (2021) (10)
- Clinical determinants of health-related quality of life in irritable bowel syndrome (2003) (9)
- Using the Rome IV Criteria to Help Manage the Complex IBS Patient (2017) (9)
- Contrasting Clinician and Insurer Perspectives to Managing Irritable Bowel Syndrome: Multilevel Modeling Analysis. (2020) (9)
- Effect of Exclusion Diets on Symptom Severity and the Gut Microbiota in Patients With Irritable Bowel Syndrome (2021) (9)
- The role of gender and bowel habit predominance on visceral perception in IBS (2001) (9)
- Evidence for decreased activation of central fear circuits by expected aversive visceral stimuli in IBS patients (2000) (9)
- Tegaserod for Irritable Bowel Syndrome With Constipation in Women Younger Than 65 Years Without Cardiovascular Disease: Pooled Analyses of 4 Controlled Trials (2021) (9)
- Benefits and Pitfalls of Change From Rome III to Rome IV Criteria for Irritable Bowel Syndrome and Fecal Incontinence. (2020) (9)
- Is there a difference between abdominal pain and discomfort in moderate to severe IBS patients (2002) (8)
- Corticotropin-releasing hormone receptor 1 (CRH-R1) polymorphisms are associated with irritable bowel syndrome and acoustic startle response (2016) (8)
- AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Constipation. (2022) (8)
- An Evidence-Based Look at Misconceptions in the Treatment of Patients with IBS-D. (2013) (8)
- 155 Predictors of Work Productivity in Irritable Bowel Syndrome (IBS): Results from the Proof Cohort (2008) (8)
- Alosetron: An Effective Treatment for Diarrhea-Predominant Irritable Bowel Syndrome (2007) (8)
- T1026 Measuring IBS Patient Reported Outcomes with a Single Item Numeric Rating Scale: Results from the PROOF Cohort (2008) (8)
- The impact of IBS on absenteeism and work productivity: United States and eight European countries (2003) (7)
- 313 Effects of Rifaximin on Urgency, Bloating, and Abdominal Pain in Patients With IBS-D: A Randomized, Controlled, Repeat Treatment Study (2015) (7)
- Risk Factors for Abdominal Pain Disorders of Gut Brain Interaction in Adults and Children: A Systematic Review. (2022) (7)
- 2015 James W. Freston Single Topic Conference: A Renaissance in the Understanding and Management of Irritable Bowel Syndrome. (2016) (7)
- GENDER-RELATED DIFFERENCES IN FUNCTIONAL GASTROINTESTINAL DISORDERS (1999) (7)
- Irritable bowel syndrome (2002) (7)
- Combined orocecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects orocecal transit, not small intestinal bacterial overgrowth in patients with irritable bowel syndrome. (2011) (6)
- Importance of trauma‐related fear in patients with irritable bowel syndrome and early adverse life events (2020) (6)
- Differences in left prefrontal activation to visceral and somatic stimuli assessed by O-15-water PET in female patients with irritable bowel syndrome (IBS) and fibromyalgia (1998) (6)
- Efficacy of Linaclotide in Reducing Abdominal Symptoms of Bloating, Discomfort, and Pain: A Phase 3B Trial Using a Novel Abdominal Scoring System. (2021) (6)
- The effect of the 5-HT3 receptor antagonist alosetron on regional brain activation in IBS patients is not dependent on activation of nociceptive visceral afferents: A H215O PET study (2001) (6)
- 1090 - Epigenetic Changes in Blood Cells and Colonic Mucosa are Associated with Irritable Bowel Syndrome (IBS) (2018) (5)
- Clinical characteristics and QOL in IBS patients from Mexico and the USA: Are they different? (2003) (5)
- The Walkerton outbreak revisited at year 8: predictors, prevalence, and prognosis of postinfectious irritable bowel syndrome. (2011) (5)
- Opioid Prescription Patterns Among US Gastroenterologists From 2013 to 2017. (2020) (5)
- 467 COMT Genetic Polymorphism Is Associated with Alterations in Attentional Processing in Patients with IBS and Other Functional Pain Syndromes (2009) (5)
- Health releated quality of life in irritable bowel syndrome: A community based study (2001) (5)
- Increasing Rates of Opioid Prescriptions for Gastrointestinal Diseases in the United States. (2021) (5)
- Price Is Right: Exploring Prescription Drug Coverage Barriers for Irritable Bowel Syndrome Using Threshold Pricing Analysis (2021) (5)
- Assessing the stability of brain activation to visceral stimulation in IBS (2001) (4)
- A3309, an Ileal Bile Acid Transport (IBAT /ASBT) Inhibitor, Significantly Improved Stool Frequency and Other Constipation-Related Complaints in Adults With Chronic Constipation: Data From an 8-Week, Randomized, Double-Blind, Placebo-Controlled Study (2011) (4)
- Mo1616 Resilience Is Decreased in Irritable Bowel Syndrome (IBS) and Associated With Poorer Quality of Life and Greater Symptom Severity (2016) (4)
- An Evidence-based Approach to Therapy in IBS-D: A Case Study Compendium. (2010) (4)
- Differences in rectal mechanoelastic properties according to predominant bowel habit in IBS patients (2000) (4)
- Contrasting Clinician and Insurer Perspectives to Managing Irritable Bowel Syndrome: Multilevel Modeling Analysis. (2021) (4)
- Do Patients Understand the Bristol Stool Scale? Results of Cognitive De-Briefing of IBS Patients (2011) (4)
- Ratings of sigmoid but not rectal distensions correlate with IBS symptom severity (2000) (4)
- Dysregulation of the Long-Noncoding RNA, Ghrlos, in Irritable Bowel Syndrome (2017) (4)
- A survey of gastroenterologists in the United States on the use of central neuromodulators for treating irritable bowel syndrome (2021) (4)
- Altered cortical and subcortical brain activation associated with autonomic responses to visceral pain in irritable bowel syndrome (IBS) (1998) (3)
- 1002 The Effect of Childhood Trauma and Abuse on the Development of Irritable Bowel Syndrome is Mediated by Somatization (2010) (3)
- Mo1550 A NOVEL SCORE TO EVALUATE ABDOMINAL SYMPTOM IMPROVEMENT IN PATIENTS WITH CONSTIPATION-PREDOMINANT IBS DEMONSTRATES EFFICACY OF LINACLOTIDE FOR IMPROVING ABDOMINAL BLOATING, DISCOMFORT, AND PAIN IN A PHASE 3B TRIAL (2020) (3)
- How to Approach a Patient with Difficult to Treat IBS. (2021) (3)
- Tu1403 Safety and Tolerability Profile of Rifaximin for Treatment of IBS Without Constipation: Results of a Pooled Analysis of Double-Blind, Placebo-Controlled Randomized Controlled Trials (2012) (3)
- Symptom criteria and severity in irritable bowel syndrome are associated with rectal sensitivity thresholds before and after sigmoid stimulation (1998) (3)
- Mo1279 Durability of Benefit in IBS-D Patients Responding to a 2-Week Course of Rifaximin: Results From TARGET 3 (2015) (3)
- Understanding the multidimensional nature of illness severity as measured by patient-reported outcome measures in irritable bowel syndrome. (2011) (3)
- 998 Glucocorticoid Receptor Gene Methylation is a Potential Biomarker of Irritable Bowel Syndrome (2012) (3)
- S1316 Patient Willingness to use ROSE-010: A Subcutaneous (SC) GLP-1 Analogue for IBS Pain Episodes (2010) (3)
- Increased Sleep Disturbances in Irritable Bowel Syndrome (IBS) Patients is Associated with Greater Symptom Severity and Decreased Quality Of Life (2017) (3)
- Cytokine Levels and Symptoms Among Women with Irritable Bowel Syndrome: Considering the Role of Hormonal Contraceptive Use (2020) (3)
- The Transition from Rome III to Rome IV Irritable Bowel Syndrome: What We Gain and Lose. (2021) (2)
- Tu1069 Do Baseline Factors Contribute to Treatment Satisfaction in Patients With Chronic Constipation Treated With Linaclotide vs Placebo (2012) (2)
- Irritable Bowel Syndrome (2004) (2)
- ORIGINAL CONTRIBUTIONS Functional GI Disorders Predictors of Patient-Assessed Illness Severity in Irritable Bowel Syndrome (2008) (2)
- Elevated levels of central stress mediators in irritable bowel syndrome (2003) (2)
- Sa1600 - Tenapanor Attenuates Increased Macromolecule Permeability in Human Colon Monolayer Cultures Induced by Inflammatory Cytokines and Human Fecal Supernatants (2018) (2)
- Evidence for selective effect of the 5HT3 antagonist alosetron on amygdala and hippocampal activation in IBS patients (2000) (2)
- 865 Patient-Reported Symptom Relief From Current Therapy is a Robust Marker of Illness Severity in IBS (2010) (2)
- IBS bowel habits and associated symptoms: forming a clearer picture. (2013) (2)
- Sa1416 Perceived Stress is Higher in IBS Than Healthy Controls and Correlates With IBS Severity Over Time (2012) (2)
- Erratum: A randomized placebo-controlled phase IIb trial of A3309, a bile acid transporter inhibitor, for chronic idiopathic constipation (American Journal of Gastroenterology (2011) 34 (41-50)) (2014) (2)
- Mo1269 Enduring Effects Following a Course of Rifaximin Therapy in Patients With IBS-D: Incremental Benefit Upon Repeat Treatment (2015) (2)
- 2015 James W. Freston Single Topic Conference: A Renaissance in the Understanding and Management of Irritable Bowel Syndrome (2016) (2)
- 366 Guanylate Cyclase-C Expression Is Down-Regulated in Colonic Biopsies From Female Irritable Bowel Syndrome Patients With Constipation (2016) (2)
- Mo1261 Characterizing the Effect of Rifaximin on Individual Symptoms of IBS-D: Findings From the Open-Label Phase of TARGET 3 (2015) (2)
- Gender-Related Differences in Functional Bowel Disorders (2004) (2)
- A mindful way through IBS: reducing abdominal pain and improving quality of life. (2012) (2)
- Updated Guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus (American Journal of Gastroenterology (March 2008) 103: 3 (788)) (2008) (2)
- Trauma Severity and Lack of Confiding in Others Increases Risk of Having Irritable Bowel Syndrome (2017) (2)
- 454 - Stressful Life Events in Adulthood Increase Risk for Irritable Bowel Syndrome and Symptom Severity (2018) (2)
- 2015 James W. Freston Single Topic Conference: A Renaissance in the Understanding and Management of Irritable Bowel Syndrome. (2016) (2)
- Effect of Eluxadoline on Abdominal and Bowel Symptoms Over Time in Phase 3 Clinical Trials in Patients With Irritable Bowel Syndrome With Diarrhea: 1761 (2015) (1)
- Effects of Linaclotide on Abdominal and Bowel Symptoms Over the First Seven Days of Treatment in Patients with Irritable Bowel Syndrome with Constipation: 1747 (2012) (1)
- Gender differences in autonomic activity in IBS (2000) (1)
- Increasing Rates of Opioid Prescriptions for Gastrointestinal Diseases in the United States. (2020) (1)
- Colonic mucosal microbiota is associated with bowel habit subtype and abdominal pain in patients with irritable bowel syndrome. (2022) (1)
- Rectosigmoid sensory measures distinguish IBS patients from controls and correlate with self ratings of GI symptom severity (2003) (1)
- Mo1262 Effects of Baseline Abdominal Pain on Response to Lubiprostone in Patients With Constipation-Predominant Irritable Bowel Syndrome (2015) (1)
- Corrigendum: Development of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) Gastrointestinal Symptom Scales (2015) (1)
- Evaluation of the Patient Reported Outcomes Measurement Information System (PROMIS) in Celiac Disease: 1066 (2016) (1)
- 677 IBS Patients Have SCN5A Mutations That Result in Decreased NaV1.5 Current and Mechanosensitivity (2015) (1)
- 847c Impact of Pain Attacks on Behavior and Health-Related Outcomes in Patients With Irritable Bowel Syndrome Meeting ROME III Criteria (2010) (1)
- Tu1390 Improvement in Quality of Life of Patients With Irritable Bowel Syndrome With Diarrhea is Sustained for 10 Weeks Following a 2-Week Course of Rifaximin (2012) (1)
- Amygdala modulation during delivered and undelivered visceral pressure (2003) (1)
- A169 EFFICACY AND SAFETY OF ELUXADOLINE IN ELDERLY PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH DIARRHEA (2018) (1)
- Mo1273 The Association of Early Adverse Life Events and Irritable Bowel Syndrome (IBS) Is Amplified by the Presence of Peritraumatic Fear (2015) (1)
- 1139 HIGH-VOLUME OPIOID PRESCRIBERS ACCOUNT FOR A SIGNIFICANT AMOUNT OF OPIOID PRESCRIPTIONS AMONG US GASTROENTEROLOGISTS FROM 2013 TO 2017 (2020) (1)
- Prevalence of extraintestinal symptoms in patients with irritable bowel syndrome and inflammatory bowel disease (1998) (1)
- Tu1406 Impact of Concurrent use of PPIs or Anti-Depressants on Efficacy of Rifaximin for IBS Without Constipation (2012) (1)
- Tu1268 - IBS-Associated Scn5A Mutation G615E Results in Nav1.5 Voltage-Dependent Sodium Channels with Normal Voltage-Dependent Function and Loss of Mechanosensitivity (2018) (1)
- Subgrouping of irritable bowel syndrome patients using traditional Chinese medicine symptom classification (2003) (1)
- A Functional Promoter Variant in the Tryptophan Hydroxylase 1 Gene is Associated With a Bowel Habit Phenotype in Patients With Irritable Bowel Syndrome (IBS) (2011) (1)
- Rifaximin Repeat Treatment in Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Produced No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity: 1790 (2015) (1)
- Colonic Mucosal Microbiome is Associated with Mucosal Microrna Expression in Irritable Bowel Syndrome (2017) (1)
- Altered diurnal rhythm of ACTH and cortisol in irritable bowel syndrome and fibromyalgia (2003) (1)
- Negative Feedback of the Hypothalamic Pituitary Adrenal (HPA) Axis as Assessed by the Dexamethasone-Corticotropin Releasing Factor (CRF) Test in Irritable Bowel Syndrome (IBS): 1778 (2015) (1)
- A national survey of irritable bowel syndrome (IBS) in females: Physician and patient perspectives (2000) (1)
- S0494 Efficacy of Tegaserod 6 mg BID for Treating Irritable Bowel Syndrome With Constipation in Women <65 Years of Age Without Cardiovascular Risk Factors: A Pooled Analysis of 4 Clinical Trials (2020) (1)
- Emerging Diagnostic and Treatment Strategies for Irritable Bowel Syndrome (2009) (1)
- Tu1895 – Colonic Mucosal Microbiome Correlates with Dietary Intake in IBS Patients and Healthy Controls (2019) (1)
- M1320 Characterizing “Bowel Urgency”: Guidance for Outcome Assessment in Patients With Diarrhea Predominant IBS (2010) (1)
- Impact of Baseline Pain Severity on the Efficacy of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea: 557 (2016) (1)
- Do the rome I and rome II criteria identify the same IBS patients (2001) (1)
- Corrigendum: A Randomized Placebo-Controlled Phase IIb Trial of A3309, A Bile Acid Transporter Inhibitor, for Chronic Idiopathic Constipation (2014) (1)
- 734 Characteristics of Acute Pain Attacks in Patients With Irritable Bowel Syndrome (IBS) Meeting ROME III Criteria (2010) (1)
- Efficacy and safety of olorinab, a full agonist of the cannabinoid receptor 2, for the treatment of abdominal pain in patients with irritable bowel syndrome: Results from a phase 2b randomized placebo‐controlled trial (CAPTIVATE) (2023) (1)
- IRRITABLE BOWEL SYNDROME AND FUNCTIONAL CONSTIPATION : SCOPE OF THE PROBLEM — (2005) (1)
- Tu1380 Assessing the Percent of Days Linaclotide Improved Abdominal Symptoms and Stool Frequency in Patients With IBS-C: A Pooled Analysis of Two Phase 3 Trials (2012) (1)
- S0492 Tegaserod 6 Mg BID for Treating Abdominal Pain and Bloating in Women With Irritable Bowel Syndrome With Constipation but Without Cardiovascular Risk Factors: A Pooled Analysis of 4 Clinical Trials (2020) (0)
- 244 Enhanced Stimulated Stress Hormone Response in Irritable Bowel Syndrome (IBS) Is Associated With Downregulation of Glucocorticoid Receptor Expression (2015) (0)
- 663 Mucosal Bitter Taste Receptor Expression in Overweight and Obese Subjects (2014) (0)
- Catecholaminergic Gene Polymorphisms and Brain Morphology and IBS (2015) (0)
- Sa1882 - Sex Differences: Early Life Adversity and Adult Stress are Associated with Alterations in the Extended Reward Network and Increased Food Addiction (2018) (0)
- Tu1065 Comparison of Responder Rates and Degree of Agreement for Symptom-Specific and Global-Relief Endpoints in Two Phase 3 Trials of Linaclotide in IBS-C (2012) (0)
- Tu1610 – Resilience in Irritable Bowel Syndrome is Lower Compared to the General Population and Other Chronic Gastrointestinal Conditions (2019) (0)
- 833 Gene Expression Profiles in Peripheral Blood Mononuclear Cells (PBMCS) Correlate With Structural and Functional Brain Networks in Chronic Visceral Pain (2015) (0)
- T2072 Colonic Mucosal Inflammation is Unlikely to Play a Primary Role in Irritable Bowel Syndrome (2010) (0)
- 97 GERD Symptoms in the General Population: Prevalence and Severity vs. Care Seeking Patients (2013) (0)
- Corrigendum: Serum and Colonic Mucosal Immune Markers in Irritable Bowel Syndrome (2012) (0)
- S0469 Linaclotide Improves Abdominal Symptoms Regardless of Baseline IBS Symptom Severity: A Post-Hoc Analysis of a Phase 3b Trial (2020) (0)
- Is IBS a Predictor of SIBO as Identified by Hydrogen/Methane Breath Testing?: 289 (2009) (0)
- Differential brain activations associated with visceral discomfort in IBS and control subjects (2003) (0)
- Comprar Irritable Bowel Syndrome · A Clinical Handbook | Harris, Lucinda A. | 9781588292681 | Springer (2007) (0)
- Irritable Bowel Syndrome · A Clinical Handbook (2007) (0)
- 401 Stress-Related Biomarkers and Symptoms Are Predictive of Irritable Bowel Syndrome (IBS) (2009) (0)
- Fr255 RIFAXIMIN IMPROVES BOTH ABDOMINAL PAIN AND BLOATING IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH DIARRHEA: A COMPOSITE ENDPOINT ANALYSIS OF TWO PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIALS (2021) (0)
- Tu1799 Differences in Cortisol Responses to Hormone Challenge vs. Visceral Stressor in Irritable Bowel Syndrome (2016) (0)
- Su1606 – Autonomic Nervous System Response in Irritable Bowel Syndrome is Associated with Sex, Bowel Habit and Gut Microbiota (2019) (0)
- M1319 Do IBS Patients Understand the Difference Between Abdominal Pain vs. Discomfort? Implications for Clinical Practice and Clinical Trial Design (2010) (0)
- 489 Opioid and Neuromodulator Prescription Patterns Among U.S. Gastroenterologists (2019) (0)
- Bowel habit predominance has a significant impact on symptoms and daily activities in women with IBS (2001) (0)
- 609 Increased Expression of μ-opioid and Cannabinoid Receptors in the Colonic Mucosa of Patients With Irritable Bowel Syndrome (IBS) (2015) (0)
- S534 Plecanatide Improves Symptoms of Chronic Idiopathic Constipation (CIC) and Irritable Bowel Syndrome With Constipation (IBS-C) Across Age Subgroups: An Analysis of Four Phase 3 Trials (2022) (0)
- Tu1364: RACE-RELATED COMPARISONS OF IRRITABLE BOWEL SYNDROME WITH CONSTIPATION SYMPTOMS, TREATMENT RESPONSE, AND QUALITY OF LIFE: RESULTS OF A POOLED ANALYSIS OF LINACLOTIDE CLINICAL TRIALS (2022) (0)
- S1378 Constipation as a Cause of Non-Responsive Celiac Disease (2021) (0)
- 410: COLONIC MUCOSAL DNA METHYLATION DIFFERENCES BETWEEN MEN AND WOMEN WITH IRRITABLE BOWEL SYNDROME COMPARED TO HEALTHY MEN AND WOMEN (2022) (0)
- 667 Corticotropin Releasing Hormone Receptor 1 (CRH-R1) Polymorphisms Are Predictive of Irritable Bowel Syndrome (IBS) Status (2013) (0)
- 918 - Correlation of Gut Microbiota-Derived Tryptophan Metabolites with Connectivity of Extended Central Reward Network in Healthy Subjects (2018) (0)
- Characterization of symptoms in IBS patients with alternating bowel habits (2003) (0)
- Mo1569 IDENTIFICATION OF COLONIC MUCOSAL MICRORNAS ALTERED IN IRRITABLE BOWEL SYNDROME AND THEIR ROLES IN INTESTINAL BARRIER FUNCTION. (2020) (0)
- 998 Irritable Bowel Syndrome (IBS) Patients Learn to Discriminate Contextual Threat Cues Associated With an Aversive Visceral Threat (2010) (0)
- Polymodal Pelvic Nerve Afferent Fibers in the Rat Effects of Intracolonic Opioid Receptor Agonists on (2015) (0)
- S1534 Longitudinal Analysis of Gluten-Free Dietary Adherence and Psychosocial Health in Gluten-Associated Disorders: The UCLA Celiac Collective (2022) (0)
- Tu1069 How Well Do Physicians Perceive Severity of Patients' Gastrointestinal Symptoms? A Comparison Across Disease States (2013) (0)
- with irritable bowel syndrome with constipation and safety of repeated tegaserod therapy in women A randomised controlled trial assessing the efficacy (2006) (0)
- Factors Analysis of Bowel Symptoms in IBS: Guidance for Patient Reported Outcome (PRO) Development (2011) (0)
- Dietary Concerns and Patient-Focused Care in Irritable Bowel Syndrome. (2022) (0)
- Mo1333 Adiposity Is Associated With Alterations Within the Brain Reward System in Adult Subjects (2015) (0)
- Su2080 Global DNA Methylation Analysis in Irritable Bowel Syndrome (2014) (0)
- Tu1409 Body Mass Index (BMI) is Associated With Gastrointestinal Symptoms in a Racially and Ethnically Diverse IBS Patient Population (2012) (0)
- Central and symptomatic correlates of rectal accommodation in IBS (2000) (0)
- S0495 The Safety Profile of Tegaserod 6 Mg BID in Irritable Bowel Syndrome With Constipation in Women <65 Years of Age Without Cardiovascular Disease History (2020) (0)
- Sa1044 Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Versus Physician Identification of Gastrointestinal Alarm Features (2015) (0)
- Mo1956 ASSOCIATION OF FECAL MICROBIOME WITH RESILIENCE IN IRRITABLE BOWEL SYNDROME PATIENTS COMPARED TO HEALTHY CONTROLS (2020) (0)
- 156 Euroqol Utilities Demonstrate Excellent Validity and Responsiveness in IBS: Results from the Proof Cohort (2008) (0)
- Mo1580 GASTROENTEROLOGISTS' PRESCRIBING PATTERNS AND COMFORT-LEVEL VARY ACROSS DIFFERENT CLASSES OF CENTRAL NEUROMODULATORS FOR TREATMENT OF IBS (2020) (0)
- Tu1370: RANDOMIZED CONTROLLED PILOT STUDY ASSESSING FRUCTOSE TOLERANCE THRESHOLDS DURING FRUCTOSE REINTRODUCTION IN NON-CONSTIPATED IBS PATIENTS SUCCESSFULLY TREATED WITH A LOW FODMAP DIET (2022) (0)
- Sex-Dependent Alterations of Colonic Epithelial Permeability in Irritable Bowel Syndrome (2017) (0)
- Do Proton Pump Inhibitors (PPIs) Predispose to the Development of SIBO in IBS versus Non-IBS Patients?: 269 (2009) (0)
- Mo2036 Genome-Wide Transcriptional Profiling Demonstrates Differences Between Irritable Bowel Syndrome (IBS), Inflammatory Bowel Disease (IBD) and Heathy Controls (2015) (0)
- Sa1327 A Multi-National Investigation of Attachment, Catastrophizing and Negative Pain Beliefs in Irritable Bowel Syndrome (2013) (0)
- Nonconstipation Irritable Bowel Syndrome (2020) (0)
- themes Stress and the Gastrointestinal Tract V . Stress and irritable bowel syndrome (2001) (0)
- 179: PATIENT-DERIVED MEANINGFUL CHANGE THRESHOLDS IN THE NOVEL ABDOMINAL SCORE OUTCOME MEASURE IN IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (2022) (0)
- Su1581 – Gpcr-Containing B7-2+ Extracellular Vesicles from Immune Cells in Blood Correlate with Irritable Bowel Syndrome Severity (2019) (0)
- Evidence for activation of central pain modulation networks in placebo-mediated pain relief in IBS patients (2003) (0)
- Tu1788 Corticotropin-Releasing Hormone Receptor 1 (CRH-R1) Polymorphisms are Associated With Irritable Bowel Syndrome (IBS) and Acoustic Startle Response (ASR) (2016) (0)
- The Effect of Sex and Irritable Bowel Syndrome (IBS) on the Integrated Hypothalamic-Pituitary-Adrenal (HPA) Axis Response to Hormone Challenge: 1780 (2015) (0)
- Tu1434 Autonomic Response to a Visceral Stressor is Dysregulated in Irritable Bowel Syndrome and Correlates With Visceral Perception (2012) (0)
- 738 INDEPENDENT EFFECTS OF RACE AND DIET ON THE BRAIN-GUT MICROBIOME AXIS IN OBESITY (2021) (0)
- 581 Catecholaminergic Genetic Polymorphisms Are Associated With Autonomic Nervous System (ANS) Function in Irritable Bowel Syndrome (2014) (0)
- 733 Characterizing Abdominal Pain Attributes in IBS: Guidance for Study Inclusion Criteria and Outcome Measurement (2010) (0)
- Expression Profiling of Sigmoid Biopsies in Irritable Bowel Syndrome vs Healthy Controls (2017) (0)
- Sa1064 Computer Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Outperforms Physician-Documented History of Presenting Illness (HPI): Results of a Blinded Comparison (2014) (0)
- Tu1802 Colonic Immune Cells in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis (2016) (0)
- Sa1911 DISTINCT BRAIN-GUT MICROBIOME ALTERATIONS IN FEMALE IBS SUBJECTS: AN ANALYSIS OF FUNCTIONAL BRAIN NETWORKS AND FECAL AMINO-ACID METABOLITES (2020) (0)
- 718 EFFECT OF EXCLUSION DIETS ON SYMPTOM SEVERITY AND GUT MICROBIOTA IN PATIENTS WITH IRRITABLE BOWEL SYNDROME (IBS) (2020) (0)
- Sa1874 – The Visceral Sensitivity Index: A Novel Tool for Measuring Gi-Symptom Specific Anxiety in Inflammatory Bowel Disease (IBD) (2019) (0)
- Prevalence of Early Adverse Life Events in Irritable Bowel Syndrome and Control Subjects (2012) (0)
- 758 Early Adverse Life Events Are Associated with Increased Responsiveness of the Hypothalamic-Pituitary-Adrenal (HPA) Axis in Individuals with and Without IBS (2009) (0)
- 569 - Brain-Gut Alterations in Germ-Free Mice Transplanted with Fecal Microbiota from IBS Patients (2018) (0)
- Mo1557 FACTORS AFFECTING CENTRAL NEUROMODULATOR USE BY GASTROENTEROLOGISTS IN THE TREATMENT OF IBS: RESULTS OF A NATIONAL SURVEY (2020) (0)
- Mo1551 - Early Life Adversity is Associated with Increased Susceptibility to Brain-Gut Alterations and Hedonic Eating Behaviors in Obesity (2018) (0)
- Resilience is Associated with Early Life Stress and HPA Axis Response in IBS (2017) (0)
- 762 Symptom Attitudes and Beliefs Predict Severity and Quality of Life in Irritable Bowel Syndrome and Partially Mediate the Effect of Depression On Quality of Life (2009) (0)
- Sa1949 – Postmenopausal Women with Irritable Bowel Syndrome (IBS) Have More Severe Symptoms Than Premenopausal Women with Ibs (2019) (0)
- Sa1598 - Dna Methylation Age Acceleration is Associated with Decreased Resilience in Irritable Bowel Syndrome (2018) (0)
- Sa328 OPIOID AND ANALGESIC PRESCRIBING PATTERNS OF HEPATOLOGISTS FOR MEDICARE BENEFICIARIES FROM 2013-2017 (2021) (0)
- Sa1015: DETERMINANTS OF OUTPATIENT OPIOID PRESCRIPTIONS FOR PATIENTS WITH CIRRHOSIS IN THE UNITED STATES (2022) (0)
- S529 Linaclotide Improves Symptoms of Irritable Bowel Syndrome With Constipation, Irrespective of Severity and Age: A Post-Hoc Analysis of Pooled Trials (2021) (0)
- NGM 2010 HOST ANMS (2010) (0)
- Sa1810 APPLICABILITY OF THE VISCERAL SENSITIVITY INDEX (VSI) AS A MEASURE OF GI SYMPTOM-SPECIFIC ANXIETY IN INFLAMMATORY BOWEL DISEASE PATIENTS (2020) (0)
- Tu1794 Functional Pathways Associated With Differential Colonic Mucosal Expression of microRNA and mRNA in Irritable Bowel Syndrome (2016) (0)
- Tu1894 – Colonic Mucosal Microbiome is Associated with Bowel Habit Subtypes in Irritable Bowel Syndrome (IBS) Patients (2019) (0)
- Tu1373: THE ASSOCIATION BETWEEN THE MEDITERRANEAN DIET AND SYMPTOMS OF IRRITABLE BOWEL SYNDROME (2022) (0)
- Su1613 – The Association of Visceral Adiposity with Irritable Bowel Syndrome, Symptom Severity, and the Hypothalamic-Pituitaryadrenal Axis Response (2019) (0)
- 1041 Efficacy of Rifaximin for IBS Without Constipation in Men and Women (2012) (0)
- Mo1288 Internal Consistency and Test-Retest Reliability of the Early Trauma Inventory Self Report-Short Form (ETI-SR) in Patients With Irritable Bowel Syndrome (IBS) and Healthy Controls (2015) (0)
- Accuracy of self-assessment of bowel habits by patients with irritable bowel syndrome* (1998) (0)
- (306/718): Characterizing effective connectivity of functional neural networks in irritable bowel syndrome (IBS) (2006) (0)
- Visceral Sensitivity Index (2016) (0)
- (135) Differential engagement and functioning of visceral- and somatic-specific pain networks in irritable bowel syndrome, irritable bowel syndrome with fibromyalgia, and healthy controls (2008) (0)
- Mo1401: SEX-SPECIFIC DIFFERENCES IN BRAIN MICROSTRUCTURAL REORGANIZATION IN IRRITABLE BOWEL SYNDROME (2022) (0)
- Sex and Gender Differences in Pain and Inflammation Effect of sex on perception of rectosigmoid stimuli in irritable bowel syndrome (2006) (0)
- M1212 Do IBS Symptoms Vary Between Men and Women? a Meta-Analysis (2009) (0)
- Fr069 HIGH OPIOID PRESCRIBING PROFILES AMONG GASTROENTEROLOGISTS: A NATIONWIDE ANALYSIS (2021) (0)
- Irritable bowel syndrome (2022) (0)
- 873: EVALUATING INCENTIVES THAT DRIVE MANAGEMENT STRATEGIES FOR UNINVESTIGATED DYSPEPSIA: NATIONAL COST-MINIMIZATION ANALYSIS IN A COMMERCIALLY INSURED POPULATION (2022) (0)
- Predictors of Quality of Life in Irritable Bowel Syndrome Compared to Healthy Controls (2017) (0)
- Mo1553 - Increased Perceived Stress is Associated with a Sexdependent Functional Change in the Brain of Irratable Bowel Syndrome Patients (2018) (0)
- Erratum: EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) Study Identifies Fecal Calprotectin, Serum MMP9, and Serum IL-22 as a Novel Combination of Biomarkers for Crohn's Disease Activity: Role of Cross-Sectional Imaging (2014) (0)
- Impact of Rifaximin on Health-Related Quality of Life in Patients with Diarrhea-Predominant Irritable Bowel Syndrome (2017) (0)
- 719 HIGH STRESS REACTIVITY IS ASSOCIATED WITH SHIFTS IN IBS PHENOTYPE AND MICROBIOME COMPOSITION/FUNCTION (2020) (0)
- Tu2065 Differences in Gastrointestinal Symptom Severity Between Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD) Patients and the General Population (2013) (0)
- Irritable Bowel Syndrome and Early Life Trauma Are Associated With an Enhanced HPA Axis Response to Hormone Stimulation (2011) (0)
- Su2065 Qualitative Assessment of Symptom Experience in Patients With Irritable Bowel Syndrome for the Development of Patient-Reported Outcome Instruments (2013) (0)
- Tu1379: PLECANATIDE PRODUCES A MORE RAPID AND SUSTAINED CLINICAL RESPONSE COMPARED TO PLACEBO IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (2022) (0)
- Tu1803 IBS-Associated SCN5A Mutation G615E Results in a NaV1.5 Channel With Normal Na+ Current Density but Loss of Mechanosensitivity (2016) (0)
- 487 Use of Central Neuromodulators by Gastroenterologists in the Treatment of IBS: A Pilot Survey (2019) (0)
- Mo1553 EVALUATION OF SENSORY SENSITIVITY AND SOMATIC AWARENESS AS INDIVIDUAL DIMENSIONS OF CHRONIC PAIN IN PATIENTS WITH IRRITABLE BOWEL SYNDROME (2020) (0)
- 734 BRAIN-GUT-MICROBIOME DIFFERENCES BETWEEN CONSTIPATION-PREDOMINANT VS. NON-CONSTIPATION-PREDOMINANT IBS (2021) (0)
- Author Index and Subject Index (2001) (0)
- Mo1293 Adverse Childhood Experiences Are Associated With Irritable Bowel Syndrome and Gastrointestinal Symptom Severity (2015) (0)
- Mo1413: RESILIENCE AND ITS NEURAL CORRELATES IN IRRITABLE BOWEL SYNDROME: INFLUENCE OF SEX (2022) (0)
- Erratum: Development of the NIH patient-reported outcomes measurement information system (PROMIS) Gastrointestinal Symptom Scales (American Journal of Gastroenterology (2014) 109 (1804-1814) DOI: 10.1038/ajg.2014.237) (2015) (0)
- P037 APPLICABILITY OF THE VISCERAL SENSITIVITY INDEX (VSI) AS A MEASURE OF GI SYMPTOM-SPECIFIC ANXIETY IN INFLAMMATORY BOWEL DISEASE PATIENTS (2020) (0)
- PATHOPHYSIOLOGY OF CHRONIC CONSTIPATION AND IRRITABLE BOWEL SYNDROME (2006) (0)
- Altered stress symptoms in response to noxious rectosigmoid stimulation in irritable bowel syndrome (IBS) (2000) (0)
- Su1033 Gender and Group Differences in Gastrointestinal Symptom Severity Between Irritable Bowel Syndrome and Inflammatory Bowel Disease Patients and the General Population (2013) (0)
- Clinical outcomes measurement (2004) (0)
- Mo1260 Comparison of Symptoms, Health Care Utilization, and Treatment in Diagnosed and Undiagnosed Patients With IBS With Diarrhea (2015) (0)
- Sa1950 – Effect of Symptom Severity and Gender on Dietary Patterns in Patients with Irritable Bowel Syndrome (2019) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Lin Chang?
Lin Chang is affiliated with the following schools:
